Abstract

The effects of follicle-stimulating hormone (FSH), cyclic AMP-dependent protein kinase (PK-A) inhibitor and dibutyryl cAMP (dbcAMP) on chromatin condensation of bovine oocytes at the germinal vesicle (GV) stage were investigated in vitro. Although germinal vesicle breakdowns (GVBD) of cumulus-enclosed and denuded oocytes were completely blocked by the protein synthesis inhibitor cycloheximide (CX), chromatin condensations in GVs occurred in 58% and 67% of the oocytes, respectively. However, when cumulus-enclosed oocytes were treated with CX plus FSH, this proportion was significantly reduced to 19%. In order to elucidate a direct correlation between PK-A activity and chromatin condensation before GVBD, GV oocytes were treated with a specific PK-A inhibitor (H-8). Under conditions inhibiting protein synthesis, treatment with H-8 dramatically increased the proportion of cumulus-enclosed oocytes possessing GVs with highly condensed bivalents, even in the presence of FSH (93%). By contrast, the proportion of denuded oocytes possessing highly condensed bivalents within GVs was significantly reduced to 26% by treatment with CX plus dbcAMP. These results indicate that PK-A activated by treatment with FSH or dbcAMP is responsible for preventing chromatin condensation before GVBD. Thus, we conclude that PK-A activity is involved in the regulation of chromatin condensation at the GV stage in bovine oocytes, regardless of the presence or absence of protein synthesis.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.